Skip to main content

Table 3 Recurrence or metastases after treatment

From: Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study

Recurrence or metastasis

CHIP group (n = 22)

IV group (n = 21)

P value

Total

14

19

0.037

Remnant gastric metastasis

5

5

0.933

Retroperitoneal lymph node metastasis

6

7

0.665

Hepatic metastasis

3

6

0.229

Peritoneal metastasis

1

7

0.021

Seroperitoneum

1

4

0.185

  1. CHIP chemotherapeutic hyperthermic intraperitoneal perfusion; IV chemotherapy alone